[PHARMA] QoQ Annualized Quarter Result on 31-Dec-2020 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
17-Mar-2021
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2020
Quarter
31-Dec-2020 [#4]
Profit Trend
QoQ- -39.04%
YoY- 118.42%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Revenue 5,471,062 3,941,244 3,173,996 2,725,071 2,787,317 2,931,368 3,279,684 40.61%
PBT 202,649 107,536 126,096 35,793 65,732 90,412 123,520 39.06%
Tax -86,596 -34,104 -34,784 -9,524 -21,310 -26,368 -33,860 86.90%
NP 116,053 73,432 91,312 26,269 44,421 64,044 89,660 18.75%
-
NP to SH 115,566 73,680 92,544 27,489 45,093 64,756 89,596 18.47%
-
Tax Rate 42.73% 31.71% 27.59% 26.61% 32.42% 29.16% 27.41% -
Total Cost 5,355,009 3,867,812 3,082,684 2,698,802 2,742,896 2,867,324 3,190,024 41.20%
-
Net Worth 391,428 357,275 355,919 337,298 345,040 357,891 350,047 7.72%
Dividend
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Div 75,056 60,200 41,872 28,761 34,852 44,409 62,695 12.73%
Div Payout % 64.95% 81.71% 45.25% 104.63% 77.29% 68.58% 69.98% -
Equity
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Net Worth 391,428 357,275 355,919 337,298 345,040 357,891 350,047 7.72%
NOSH 1,309,126 261,991 261,705 261,705 261,705 261,705 261,229 192.55%
Ratio Analysis
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
NP Margin 2.12% 1.86% 2.88% 0.96% 1.59% 2.18% 2.73% -
ROE 29.52% 20.62% 26.00% 8.15% 13.07% 18.09% 25.60% -
Per Share
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
RPS 417.92 301.16 1,212.81 1,042.20 1,066.33 1,122.12 1,255.48 -51.93%
EPS 8.83 5.64 35.36 10.51 17.25 24.78 34.28 -59.48%
DPS 5.73 4.60 16.00 11.00 13.33 17.00 24.00 -61.48%
NAPS 0.299 0.273 1.36 1.29 1.32 1.37 1.34 -63.17%
Adjusted Per Share Value based on latest NOSH - 261,705
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
RPS 379.60 273.46 220.22 189.08 193.40 203.39 227.56 40.61%
EPS 8.02 5.11 6.42 1.91 3.13 4.49 6.22 18.44%
DPS 5.21 4.18 2.91 2.00 2.42 3.08 4.35 12.76%
NAPS 0.2716 0.2479 0.247 0.234 0.2394 0.2483 0.2429 7.72%
Price Multiplier on Financial Quarter End Date
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Date 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 -
Price 0.835 5.29 3.26 5.00 4.32 2.22 1.26 -
P/RPS 0.20 1.76 0.27 0.48 0.41 0.20 0.10 58.67%
P/EPS 9.46 93.96 9.22 47.56 25.04 8.96 3.67 87.88%
EY 10.57 1.06 10.85 2.10 3.99 11.17 27.22 -46.74%
DY 6.87 0.87 4.91 2.20 3.09 7.66 19.05 -49.30%
P/NAPS 2.79 19.38 2.40 3.88 3.27 1.62 0.94 106.39%
Price Multiplier on Announcement Date
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Date 19/11/21 20/08/21 21/05/21 17/03/21 19/11/20 19/08/20 19/05/20 -
Price 0.845 0.925 4.03 3.49 5.72 4.42 1.88 -
P/RPS 0.20 0.31 0.33 0.33 0.54 0.39 0.15 21.12%
P/EPS 9.57 16.43 11.40 33.20 33.16 17.83 5.48 44.96%
EY 10.45 6.09 8.77 3.01 3.02 5.61 18.24 -30.99%
DY 6.79 4.97 3.97 3.15 2.33 3.85 12.77 -34.34%
P/NAPS 2.83 3.39 2.96 2.71 4.33 3.23 1.40 59.80%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment